scispace - formally typeset
R

Ruchika Bhat

Researcher at Indian Institute of Technology Delhi

Publications -  14
Citations -  61

Ruchika Bhat is an academic researcher from Indian Institute of Technology Delhi. The author has contributed to research in topics: Hepatitis B virus & Medicine. The author has an hindex of 4, co-authored 10 publications receiving 30 citations. Previous affiliations of Ruchika Bhat include Indian Institutes of Technology.

Papers
More filters
Journal ArticleDOI

Improving the binding affinity estimations of protein–ligand complexes using machine-learning facilitated force field method

TL;DR: A new scoring function Bappl+ is presented that is designed to predict the binding affinities of non-metallo and metallo PL complexes and outperforms other state-of-the-art scoring functions, achieving a high Pearson correlation coefficient.
Journal ArticleDOI

Toward development of generic inhibitors against the 3C proteases of picornaviruses.

TL;DR: This work has targeted the 3C protease of Hepatitis A Virus, a feco‐orally transmitted virus of the family Picornaviridae, for identification of potential antivirals and identified a few compounds which could inhibit HAV 3C activity.
Journal ArticleDOI

Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approaches.

TL;DR: The present study identified twenty plant bioactive compounds that are available at low price and do not have associated adverse effect against Chikungunya virus, and reveals five potential lead compounds having high binding energy that can help in the development of commercial drugs with favorable ADMET characteristic.
Journal ArticleDOI

Epidemiology and molecular characterization of chikungunya virus from human cases in North India, 2016.

TL;DR: In this paper, epidemiology and molecular characterization of three whole-genome sequences of chikungunya virus and assessed phylogenetic analysis, physiological properties, antigenicity, and B-cell epitope prediction by in silico.
Journal ArticleDOI

A comprehensive automated computer-aided discovery pipeline from genomes to hit molecules

TL;DR: Dhanvantari, a comprehensive software suite which automates the journey from genomes to hit molecules via its various modules such as gene finding, computational structural study of target proteins and virtual screening/identification of hit molecules for computer aided drug discovery is proposed.